A rapid and ultra-sensitive dual readout platform for Klebsiella pneumoniae detection based on RPA-CRISPR/Cas12a
Frontiers in Cellular and Infection Microbiology · 27.06.2024 · 14
DOI: 10.3389/fcimb.2024.1362513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 27.06.2024. Verfasst von Meiying Tan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Medical Laboratory Science, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, CRISPR-Cas Systems, Sensitivity and Specificity, Nucleic Acid Amplification Techniques. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The bacterium Klebsiella pneumoniae ( Kp ) was the primary pathogen of hospital-acquired infection, but the current detection method could not rapidly and conveniently identify Kp . Recombinase polymerase amplification (RPA) was a fast and convenient isothermal amplification technology, and the clustered regularly interspaced short palindromic repeats (CRISPR) system could rapidly amplify the signal of RPA and improve its limit of detection (LOD). In this study, we designed three pairs of RPA primers for the rcsA gene of Kp , amplified the RPA signal through single-strand DNA reporter cleavage by CRISPR/Cas12a, and finally analyzed the cleavage signal using fluorescence detection (FD) and lateral flow test strips (LFTS). Our results indicated that the RPA-CRISPR/Cas12a platform could specifically identify Kp from eleven common clinical pathogens. The LOD of FD and LFTS were 1 fg/μL and 10 fg/μL, respectively. In clinical sample testing, the RPA-CRISPR/Cas12a platform was consistent with the culture method and qPCR method, and its sensitivity and specificity were 100% (16/16) and 100% (9/9), respectively. With the advantages of detection speed, simplicity, and accuracy, the RPA-CRISPR/Cas12a platform was expected to be a convenient tool for the early clinical detection of Kp .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Medical Laboratory Science, Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
- Baise Key Laboratory for Research and Development on Clinical Molecular Diagnosis for High-Incidence Diseases, Guangxi, China.
- Key Laboratory of Research on Clinical Molecular Diagnosis for High Incidence Diseases in Western Guangxi, Guangxi, China.
- Department of Clinical Laboratory, Baise People's Hospital, Guangxi, China.
- School of Food and Chemical Engineering, Liuzhou Institute of Technology, Guangxi, China.
- Department of Neurology, The Affiliated Hospital of Youjiang Medical University for Nationalities, Guangxi, China.
Zitieren
APA
Tan, M., Liang, L., Liao, C., Zhou, Z., Long, S., Yi, X., Wang, C., Wei, C., Cai, J., Li, X., & Wei, G. (2024). A rapid and ultra-sensitive dual readout platform for Klebsiella pneumoniae detection based on RPA-CRISPR/Cas12a. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1362513
Vancouver
Tan M, Liang L, Liao C, Zhou Z, Long S, Yi X, et al. A rapid and ultra-sensitive dual readout platform for Klebsiella pneumoniae detection based on RPA-CRISPR/Cas12a. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1362513
BibTeX
@article{Tan2024,
author = {Tan, Meiying and Liang, Lina and Liao, Chuan and Zhou, Zihan and Long, Shaoping and Yi, Xueli and Wang, Chunfang and Wei, Caiheng and Cai, Jinyuan and Li, Xuebin and Wei, Guijiang},
title = {A rapid and ultra-sensitive dual readout platform for Klebsiella pneumoniae detection based on RPA-CRISPR/Cas12a},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
volume = {14},
doi = {10.3389/fcimb.2024.1362513}
}
EUVIMED